Top

Published in:

01-12-2017 | Case report

Alemtuzumab

Alopecia totalis: case report

Published in: Reactions Weekly | Issue 1/2017

Excerpt

» Editorial comment: Details of this case report have previously been published [see Reactions 1681 p26; 803286067]. The author stated that the patient reported alopecia after 18 months of the first exposure. …

Zimmermann J, et al. Alopecia totalis following alemtuzumab treatment in relapsing-remitting multiple sclerosis. Multiple Sclerosis Journal 23 (Suppl. 1): 382 abstr. P761, No. 3, Oct 2017. Available from: URL: http://doi.org/10.1177/1352458517731404 [abstract] - Germany

Title: Alemtuzumab
Alopecia totalis: case report
Publication date: 01-12-2017
Publisher: Springer International Publishing
Published in: Reactions Weekly / Issue 1/2017
Print ISSN: 0114-9954
Electronic ISSN: 1179-2051
DOI: https://doi.org/10.1007/s40278-017-39301-5

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Alemtuzumab

Alopecia totalis: case report

Excerpt

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Excerpt

Please log in to get access to this content

Other articles of this Issue 1/2017

Rituximab

Heparin

Rivaroxaban withdrawal

Gemcitabine/paclitaxel

BCG

BCG